Vibgyor Drugs Private Limited - Company Profile

It is a pharma private limited company based in Kamareddy, Telangana, India, established in 2009.
2009 Kamareddy, Telangana, India Active
Last Updated:
Access Report
About Vibgyor Drugs Private Limited

Vibgyor Drugs Private Limited, a active private limited company, was established on 20 March 2009 in Kamareddy, Telangana, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24100TG2009PTC063120. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹5.00 Cr and a paid-up capital of ₹5.00 Cr.

It upholds a compliant status. Employing 15 professional, Its leadership includes Venkata Ravindra Koganti (Managing Director), Geetha Sree Koganti (Director). Past directors included Raja Sekhara Rao Narayanam, Ravi Chikkala, Satyendra Kumar Singh. It holds ₹1.20 Cr open charges and ₹4.95 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Sy.No. 306 & 307, Jangampally (V), Opp: Divya Restaurant, Domakonda Service Road, Bhik, Noor (M), Kamareddy, Telangana, 503102.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24100TG2009PTC063120

  • Registration Number

    063120

  • Incorporation Date

    20 March 2009

  • Authorized Capital

    ₹5.00 Cr

  • Paid-Up Capital

    ₹5.00 Cr

  • ROC Code

    Roc Hyderabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 5.00 Cr
  • Company Age 16 Year, 11 Months
  • Last Filing with ROC 31 Mar 2025
  • Open Charges ₹ 1.20 Cr
  • Satisfied Charges ₹ 4.95 Cr
  • Revenue Growth **** 215.18%
  • Profit Growth **** 159.50%
  • Ebitda **** -5.80%
  • Net Worth 1.24%
  • Total Assets **** 14.23%
Company report

Vibgyor Drugs Private Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Vibgyor Drugs Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Vibgyor Drugs Private Limited?
Current Directors
Name Designation Appointment Date Status
Venkata Ravindra Koganti Managing Director 05 Dec 2014 Current
Geetha Sree Koganti Director 28 Nov 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Managing Director 11 Jul 2013 Past
Pramod Abcsdd Additional Director 14 Nov 2012 Past
Pramod Abcsdd Additional Director 06 Jun 2016 Past
Pramod Abcsdd Director 17 Aug 2022 Past
Pramod Abcsdd Director 12 Aug 2015 Past
Pramod Abcsdd Whole-Time Director 26 Aug 2014 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Vibgyor Drugs.

Vibgyor Drugs Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 215.18% increase. The company also saw a substantial improvement in profitability, with a 159.5% increase in profit. The company's net worth moved up by a moderate rise of 1.24%.

Vibgyor Drugs revenue growth over time
Vibgyor Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 215.18%
*******
*******
*******
*******
Revenue from Operations
*******
 215.33%
*******
*******
*******
*******
Total Assets
*******
 14.23%
*******
*******
*******
*******
Profit or Loss
*******
 159.50%
*******
*******
*******
*******
Net Worth
*******
 1.24%
*******
*******
*******
*******
EBITDA
*******
 -5.80%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Vibgyor Drugs?

In 2022, Vibgyor Drugs had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹12,000,000.00

Satisfied Charges

₹49,500,000.00

Charges Breakdown by Lending Institutions
  • Syndicate Bank : 1.20 Cr
Latest Charge Details
Date Lender Amount Status
12 Dec 2018 Syndicate Bank ₹1.20 Cr Open
24 Dec 2014 Syndicate Bank ₹4.95 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Vibgyor Drugs?

Vibgyor Drugs has a workforce of 15 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Vibgyor Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vibgyor Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Vibgyor Drugs
Recent Activity within the Organization
  • Annual General Meeting

    Vibgyor Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.

  • Balance Sheet

    Progress on Vibgyor Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Hyderabad. was documented.

  • Charges

    The activity A charge registered on 24 Dec 2014 via Charge ID 10543406 with Syndicate Bank was fully satisfied on 16 Nov 2022. was completed.

  • Charges

    Progress on A charge with Syndicate Bank amounted to Rs. 1.20 Cr with Charge ID 100232637 was registered on 12 Dec 2018. was documented.

  • Director Appointment

    Geetha Sree Koganti was appointed as a Director was appointed as a Director on 28 Nov 2015 & has been associated with this company since 10 years 2 months . was recorded as a recent event.

  • Charges

    Progress on A charge with Syndicate Bank amounted to Rs. 4.95 Cr with Charge ID 10543406 was registered on 24 Dec 2014. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Vibgyor Drugs Private Limited?

The CIN of Vibgyor Drugs Private Limited is U24100TG2009PTC063120.

Where is Vibgyor Drugs Private Limited headquartered?

Vibgyor Drugs Private Limited is headquartered at Sy.No. 306 & 307, Jangampally (V), Opp: Divya Restaurant, Domakonda Service Road, Bhik, Noor (M), Kamareddy, Telangana, 503102.

When was Vibgyor Drugs Private Limited incorporated?

Vibgyor Drugs Private Limited was incorporated on 20 March 2009.

Who are the current directors of Vibgyor Drugs Private Limited?

The current directors of Vibgyor Drugs Private Limited are

What is the primary industry of Vibgyor Drugs Private Limited?

The primary industry of Vibgyor Drugs Private Limited is Manufacturing.

Is Vibgyor Drugs Private Limited a listed company?

Vibgyor Drugs Private Limited is unlisted.

What is the capital structure of Vibgyor Drugs Private Limited?

The authorized capital of Vibgyor Drugs Private Limited is ₹5.00 Cr, and the paid-up capital is ₹5.00 Cr.

What is the compliance status of Vibgyor Drugs Private Limited?

The compliance status of Vibgyor Drugs Private Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available